Visits: 2525, Avg visit time (secs): 237,24 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1344 | 53,23% | |
| /pfizer/efsd-pfizer-rfa09.html | 249 | 9,86% |
| /programmes.html | 170 | 6,73% |
| /amylin/efsd-amylin-rfa09.html | 141 | 5,58% |
| /lilly/fellowships/efsd-lilly-fship09.html | 76 | 3,01% |
| /msd/albert-renold/efsd-msd-arenold.html | 43 | 1,70% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 42 | 1,66% |
| /lifescan/efsd-lifescan-rfa09.html | 40 | 1,58% |
| /regulations.html | 30 | 1,19% |
| /msd/clinical/efsd-msd-clinical-rfa10.html | 23 | 0,91% |
| /novartis/efsd-novartis-rfa09.html | 20 | 0,79% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1268 | 50,22% |
| /pfizer/efsd-pfizer-rfa09.html | 225 | 8,91% |
| /sanofi-aventis/micro_macro/s-a 10 rfa.html | 191 | 7,56% |
| /recipients.html | 113 | 4,48% |
| /msd/albert-renold/efsd-msd-arenold.html | 75 | 2,97% |
| /amylin/efsd-amylin-rfa09.html | 54 | 2,14% |
| /lilly/fellowships/efsd-lilly-fship09.html | 50 | 1,98% |
| /lifescan/efsd-lifescan-rfa09.html | 45 | 1,78% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 42 | 1,66% |
| /programmes.html | 40 | 1,58% |
| /home.html | 39 | 1,54% |